96 related articles for article (PubMed ID: 27779695)
1. Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinoma‑bearing subcutaneous tumor mouse model.
Li CH; Lim SH; Ryu HH; Moon KS; Jung TY; Jung S
Oncol Rep; 2016 Dec; 36(6):3397-3404. PubMed ID: 27779695
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Lim SH; Li CH; Jeong YI; Jang WY; Choi JM; Jung S
Int J Nanomedicine; 2019; 14():8861-8874. PubMed ID: 32009784
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Effects of Radiotherapy With JNK Inhibitor-Incorporated Nanoparticle in an Intracranial Lewis Lung Carcinoma Mouse Models.
Li CH; Lim SH; Jeong YI; Ryu HH; Jung S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):845-854. PubMed ID: 37022021
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
[TBL] [Abstract][Full Text] [Related]
5. Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest.
Bulgin D; Podtcheko A; Takakura S; Mitsutake N; Namba H; Saenko V; Ohtsuru A; Rogounovitch T; Palona I; Yamashita S
Thyroid; 2006 Mar; 16(3):217-24. PubMed ID: 16571083
[TBL] [Abstract][Full Text] [Related]
6. FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells.
Ju Y; Xu T; Zhang H; Yu A
Int J Oncol; 2014 Apr; 44(4):1284-92. PubMed ID: 24452601
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung.
Wu S; Kasisomayajula K; Peng J; Bancalari E
Pediatr Res; 2009 Apr; 65(4):381-6. PubMed ID: 19127219
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway.
Gao Y; Signore AP; Yin W; Cao G; Yin XM; Sun F; Luo Y; Graham SH; Chen J
J Cereb Blood Flow Metab; 2005 Jun; 25(6):694-712. PubMed ID: 15716857
[TBL] [Abstract][Full Text] [Related]
10. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.
Kim YJ; Lee WS; Ip C; Chae HZ; Park EM; Park YM
Cancer Res; 2006 Jul; 66(14):7136-42. PubMed ID: 16849559
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B
J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722
[TBL] [Abstract][Full Text] [Related]
12. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Sayeed A; Lu H; Liu Q; Deming D; Duffy A; McCue P; Dicker AP; Davis RJ; Gabrilovich D; Rodeck U; Altieri DC; Languino LR
Oncotarget; 2016 Aug; 7(33):52618-52630. PubMed ID: 27438371
[TBL] [Abstract][Full Text] [Related]
13. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
[TBL] [Abstract][Full Text] [Related]
14. MAPK regulation and caspase activation are required in DMNQ S-52 induced apoptosis in Lewis lung carcinoma cells.
Lee SJ; Sakurai H; Koizumi K; Song GY; Bae YS; Kim HM; Kang KS; Surh YJ; Saiki I; Kim SH
Cancer Lett; 2006 Feb; 233(1):57-67. PubMed ID: 15893420
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
Chen LW; Chang WJ; Wang JS; Hsu CM
Crit Care Med; 2007 Apr; 35(4):1113-22. PubMed ID: 17334237
[TBL] [Abstract][Full Text] [Related]
16. 2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation.
Zou H; Adachi M; Imai K; Hareyama M; Yoshioka K; Zhao S; Shinomura Y
Clin Cancer Res; 2006 Nov; 12(21):6532-9. PubMed ID: 17085668
[TBL] [Abstract][Full Text] [Related]
17. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
18. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
[TBL] [Abstract][Full Text] [Related]
20. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
Yamamoto T; Digumarthi H; Aranbayeva Z; Wataha J; Lewis J; Messer R; Qin H; Dickinson D; Osaki T; Schuster GS; Hsu S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):318-25. PubMed ID: 17196232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
